|
IMVT Immunovant Inc 1764013 |
| Balance Sheet |
|
Current Assets
|
507,372,000 |
|
Assets
|
515,707,000 |
|
Current Liabilities
|
66,653,000 |
|
Liabilities
|
66,653,000 |
|
Equity
|
449,054,000 |
|
Shares Out
|
146,367,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-164,846,000 |
|
Investing Cash Flow
|
-378,000 |
| Market Analysis |
Market Cap
|
4,269,534,152 |
|
Price
|
23.86 |
|
BVPS
|
3.07 |
|
PB
|
7.78 |
|
EPS
|
-1.92 |
|
PS
|
1.15 |
|
FCF
|
-165,224,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMVT documents filed with the SEC.
IMVT Filings
Clear
